rs8111947

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001364171.2(ODAD1):​c.1404+8A>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.354 in 1,610,912 control chromosomes in the GnomAD database, including 104,786 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.37 ( 10563 hom., cov: 30)
Exomes 𝑓: 0.35 ( 94223 hom. )

Consequence

ODAD1
NM_001364171.2 splice_region, intron

Scores

2
Splicing: ADA: 0.00001091
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -2.32

Publications

11 publications found
Variant links:
Genes affected
ODAD1 (HGNC:26560): (outer dynein arm docking complex subunit 1) This gene encodes a coiled-coil domain-containing protein that is a component of the outer dynein arm docking complex in cilia cells. Mutations in this gene may cause primary ciliary dyskinesia 20. [provided by RefSeq, May 2013]
ODAD1 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 20
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BP6
Variant 19-48298169-T-C is Benign according to our data. Variant chr19-48298169-T-C is described in ClinVar as Benign. ClinVar VariationId is 262486.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.438 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ODAD1NM_001364171.2 linkc.1404+8A>G splice_region_variant, intron_variant Intron 13 of 15 ENST00000674294.1 NP_001351100.1
ODAD1NM_144577.4 linkc.1293+8A>G splice_region_variant, intron_variant Intron 11 of 13 NP_653178.3 Q96M63-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ODAD1ENST00000674294.1 linkc.1404+8A>G splice_region_variant, intron_variant Intron 13 of 15 NM_001364171.2 ENSP00000501363.1 A0A6I8PTZ2

Frequencies

GnomAD3 genomes
AF:
0.366
AC:
55257
AN:
150932
Hom.:
10542
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.443
Gnomad AMI
AF:
0.231
Gnomad AMR
AF:
0.262
Gnomad ASJ
AF:
0.441
Gnomad EAS
AF:
0.128
Gnomad SAS
AF:
0.278
Gnomad FIN
AF:
0.337
Gnomad MID
AF:
0.420
Gnomad NFE
AF:
0.369
Gnomad OTH
AF:
0.364
GnomAD2 exomes
AF:
0.318
AC:
79524
AN:
249742
AF XY:
0.324
show subpopulations
Gnomad AFR exome
AF:
0.437
Gnomad AMR exome
AF:
0.175
Gnomad ASJ exome
AF:
0.442
Gnomad EAS exome
AF:
0.127
Gnomad FIN exome
AF:
0.333
Gnomad NFE exome
AF:
0.368
Gnomad OTH exome
AF:
0.333
GnomAD4 exome
AF:
0.353
AC:
515679
AN:
1459860
Hom.:
94223
Cov.:
42
AF XY:
0.352
AC XY:
255473
AN XY:
726314
show subpopulations
African (AFR)
AF:
0.448
AC:
14990
AN:
33464
American (AMR)
AF:
0.186
AC:
8331
AN:
44680
Ashkenazi Jewish (ASJ)
AF:
0.443
AC:
11560
AN:
26122
East Asian (EAS)
AF:
0.115
AC:
4576
AN:
39690
South Asian (SAS)
AF:
0.290
AC:
24997
AN:
86236
European-Finnish (FIN)
AF:
0.330
AC:
17128
AN:
51926
Middle Eastern (MID)
AF:
0.386
AC:
2227
AN:
5766
European-Non Finnish (NFE)
AF:
0.369
AC:
410665
AN:
1111612
Other (OTH)
AF:
0.351
AC:
21205
AN:
60364
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
17392
34784
52177
69569
86961
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
12844
25688
38532
51376
64220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.366
AC:
55313
AN:
151052
Hom.:
10563
Cov.:
30
AF XY:
0.360
AC XY:
26564
AN XY:
73724
show subpopulations
African (AFR)
AF:
0.443
AC:
18230
AN:
41120
American (AMR)
AF:
0.261
AC:
3961
AN:
15148
Ashkenazi Jewish (ASJ)
AF:
0.441
AC:
1528
AN:
3468
East Asian (EAS)
AF:
0.128
AC:
645
AN:
5024
South Asian (SAS)
AF:
0.276
AC:
1324
AN:
4790
European-Finnish (FIN)
AF:
0.337
AC:
3520
AN:
10454
Middle Eastern (MID)
AF:
0.400
AC:
116
AN:
290
European-Non Finnish (NFE)
AF:
0.369
AC:
25020
AN:
67756
Other (OTH)
AF:
0.363
AC:
758
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1759
3518
5277
7036
8795
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
532
1064
1596
2128
2660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.373
Hom.:
4598
Bravo
AF:
0.362
Asia WGS
AF:
0.212
AC:
743
AN:
3478
EpiCase
AF:
0.375
EpiControl
AF:
0.369

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

not provided Benign:2
Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Primary ciliary dyskinesia Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.95
CADD
Benign
0.64
DANN
Benign
0.49
PhyloP100
-2.3
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000011
dbscSNV1_RF
Benign
0.0040
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs8111947; hg19: chr19-48801426; COSMIC: COSV59558635; API